Spatial genomics analysis of tumor samples

Ended Project Grant Awarded Last action

Award ID
R44CA285121
Recipient
Awarding agency
Obligated
$1,996,962

Award facts

Assistance listing
93.396 Cancer Biology Research
Completion date
Place of performance
California, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
Imaging the tumor microenvironment (TME) is key to understanding tumor growth, disease progression and therapy options. The TME often consists of a complex neighborhood of diverse populations of immune cells, fibroblasts, and tumors cells. Little is known about the "geography" of the tumors and the spatial organization of the distinct cell types. The ability to rapidly identify different cell types and tumor subtypes using molecular markers will be transformative for cancer diagnostics. At spatial genomics, we are commercializing technology that allows transcript profiling in tumor samples. With this technology, cell types in situ and spatial organizations can be directly identified and visualized in tumor tissue slices. These capabilities provide a powerful tool for examining the different cell types and their interactions in the tumor microenvironment. In this proposal, we will develop the reagents, instrumentation, and the associated software that will allow researchers to perform spatial mapping experiments in tumor slices.

Transactions

Action Obligated Date
Amendment $0
Amendment $998,481
Original award $998,481

Quick answers

Who received award R44CA285121?

R44CA285121 was awarded to Spatial Genomics, Inc. by National Cancer Institute (National Institutes of Health) on September 1, 2023.

How much is award R44CA285121 worth?

$1,996,962 has been obligated on R44CA285121.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login